Bagan Sean 4
4 · HELIOS TECHNOLOGIES, INC. · Filed Mar 9, 2026
Research Summary
AI-generated summary of this filing
Helios (HLIO) CEO Sean Bagan Receives Equity Awards
What Happened
Sean Bagan, President & CEO and a director of Helios Technologies (HLIO), received a one-time equity award on March 5, 2026. That award included 3,698 shares that were settled immediately (priced at $67.61 each, valued at $250,022) and two derivative components: 18,770 restricted stock units (RSUs) and 38,846 performance stock options granted the same day. All items are coded as awards/grants (Form 4 transaction code A).
Key Details
- Transaction date: March 5, 2026; Form 4 filed March 9, 2026 (filed within the required two business days).
- Settled shares: 3,698 shares acquired at $67.61 per share = $250,022 total.
- RSUs: 18,770 units granted (derivative, $0 acquisition price reported). Per footnote, generally 33⅓% of these RSUs vest/convert on Jan 3 of 2027, 2028 and 2029.
- Performance options: 38,846 performance-based stock options (derivative, $0 price reported). These represent the right to receive up to 225% of the number of options awarded, vesting and payout tied to pre-established performance metrics over a three-year performance period (FY2026–FY2028) and subject to continued employment through March 15, 2029; options expire 10 years from grant.
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Transaction type: Award/Grant (A) — not an open-market purchase or sale.
Context
- The immediate settlement (3,698 shares) delivered roughly $250K in stock to the CEO and was part of a broader special equity award. The RSUs and performance options are derivative awards with time- and performance-based vesting, so their ultimate share delivery depends on future vesting conditions and any performance outcomes.
- Awards like these are compensation-related and do not necessarily signal a personal purchase or sale decision by the insider.
Insider Transaction Report
Form 4
Bagan Sean
DirectorPresident and CEO
Transactions
- Award
Common Stock
[F1]2026-03-05$67.61/sh+3,698$250,022→ 19,632 total - Award
Restricted Stock Units
[F2]2026-03-05+18,770→ 18,770 totalExercise: $0.00→ Common Stock (18,770 underlying) - Award
Performance Stock Options (right to buy)
[F3]2026-03-05+38,846→ 38,846 totalExercise: $67.61→ Common Stock (38,846 underlying)
Footnotes (3)
- [F1]The restricted stock units granted to the reporting person on March 5, 2026, were approved by the Company's Compensation Committee as a one-time special equity award. The award vested immediately upon grant on March 5, 2026, and was settled in shares of the Company's Common Stock on a one-for-one basis on the same date, subject to the reporting person's continued employment through the vesting date.
- [F2]Each RSU represents the right to receive, following vesting, one share of Common Stock. Unless earlier forfeited under the terms of the RSU, 33-1/3% of the awards vest and convert into Common Stock on each of January 3, 2027, January 3, 2028, and January 3, 2029.
- [F3]The performance stock options granted to the reporting person on March 5, 2026, represent the right to receive, following vesting, a number of stock options up to 225% of the number of stock options. The number of performance stock options acquired upon vesting is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, over a three-year performance period beginning on the first day of the fiscal year of 2026 and ending the last day of the fiscal year of 2028, subject to continuous employment with the Company through March 15, 2029. Stock options expire 10 years from the date of grant.
Signature
/s/ Marc Greenberg, Attorney-in-fact for Sean Bagan|2026-03-09